Introduction Since the COVID-19 pandemic, self-medication had become highly popular due
to the risk of virus infection and overwhelming medical resources. Pharmacists are well …

The global pandemic of COVID-19 is currently ongoing. Clinical evidence shows that
specific population groups such as the elderly, individuals with comorbidities, and pregnant …

Information on medication utilization among pregnant and postpartum women during the
pandemic is lacking. We described the prevalence and patterns of self-reported medication …

Evidence indicates that SARS-CoV-2 infection increases the likelihood of adverse
pregnancy outcomes. Modifications in the circulatory, pulmonary, hormonal, and …

Pharmacological treatment may become a barrier for a mother's breastfeeding goals. We
aimed to investigate maternal medication intake as a factor for non-initiation and cessation …

Background: In this study, an investigation was conducted on clinical drug trials comprising
pregnant women in China that provided data on the quantity, properties, source of funding …

Women's physiological changes in pregnancy and breastfeeding may alter the
pharmacokinetics and the pharmacodynamics of many drugs, resulting in potential risks to …

Pharmacotherapy is a very powerful approach to truly improve outcomes for pregnant
women and their newborns. Associated with changes in the clinical characteristics of …

There is limited evidence about the use of medications among pregnant women with COVID‐
19, as well as risk factors for hospitalization due to COVID‐19 in pregnancy. We aimed to …

Objectives In this study, we aimed to systematically review the literature of the prevalence of
systemic antibacterial use during pregnancy and to perform a descriptive analysis focused …